Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 94 Total
MDB - MongoDB Inc - Stock Price Chart
TickerMDB [NASD, NDX]
CompanyMongoDB Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap23.25BEPS (ttm)-2.48
P/E-EPS this Y-26.97%
Forward P/E96.44EPS next Y35.15%
PEG-EPS past 5Y-5.43%
P/S13.81EPS next 5Y-
P/B21.57EPS Q/Q17.23%
Dividend-Sales Q/Q26.76%
Insider Own3.55%Inst Own90.17%
Insider Trans-10.29%Inst Trans1.63%
Short Float5.99%EarningsMay 30/a
Analyst Recom1.73Target Price437.10
Avg Volume1.32M52W Range275.76 - 509.62
MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MERRIMAN DWIGHT ADirectorMay 03 '24Sale374.956,0002,249,7061,148,784May 03 04:47 PM
MERRIMAN DWIGHT ADirectorMay 01 '24Sale379.151,000379,150522,896May 03 04:47 PM
MERRIMAN DWIGHT ADirectorApr 08 '24Sale365.002,000730,0001,154,784Apr 11 04:17 PM
Pech CedricChief Revenue OfficerApr 04 '24Sale350.004,7261,654,10035,992Apr 08 04:06 PM
Pech CedricChief Revenue OfficerApr 03 '24Sale343.364,7261,622,71940,718Apr 03 07:30 PM
PD - Pagerduty Inc - Stock Price Chart
TickerPD [NYSE, RUT]
CompanyPagerduty Inc
CountryUSA
IndustrySoftware - Application
Market Cap1.76BEPS (ttm)-0.89
P/E-EPS this Y-8.48%
Forward P/E22.34EPS next Y21.94%
PEG-EPS past 5Y-10.26%
P/S4.09EPS next 5Y30.00%
P/B9.97EPS Q/Q-22.16%
Dividend-Sales Q/Q10.05%
Insider Own6.34%Inst Own90.51%
Insider Trans-1.05%Inst Trans0.76%
Short Float13.35%EarningsMay 30/a
Analyst Recom1.90Target Price26.02
Avg Volume1.12M52W Range19.15 - 28.27
PagerDuty, Inc. operates a digital operations management platform. It provides incident management solution that integrates with information technology Ops and DevOps monitoring stacks to improve operational reliability and agility. The firm collects machine generated data from virtually any software-enabled system or device, combines it with human response data, correlating and interpreting this data to understand issues and opportunities that need to be addressed in real-time. The company was founded by Andrew Miklas, Baskar Puvanathasan, and Dan Alexandru Solomon in 2009 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEBB SHELLEYChief Legal OfficerApr 04 '24Sale22.396,859153,595253,439Apr 08 05:36 PM
REZVAN MITRASVP Finance & CAOApr 02 '24Sale21.622,21547,888119,452Apr 04 08:48 PM
Wilson HowardChief Financial OfficerFeb 12 '24Option Exercise7.435,00037,150516,565Feb 15 08:16 PM
Wilson HowardChief Financial OfficerFeb 12 '24Sale25.098,893223,125507,672Feb 15 08:16 PM
Wilson HowardChief Financial OfficerJan 12 '24Option Exercise7.435,00037,150516,565Jan 17 08:32 PM
BASE - Couchbase Inc - Stock Price Chart
TickerBASE [NASD, RUT]
CompanyCouchbase Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap1.22BEPS (ttm)-1.70
P/E-EPS this Y24.10%
Forward P/E-EPS next Y58.11%
PEG-EPS past 5Y-23.52%
P/S6.76EPS next 5Y-
P/B9.13EPS Q/Q-20.25%
Dividend-Sales Q/Q20.34%
Insider Own27.94%Inst Own72.83%
Insider Trans-2.55%Inst Trans-1.11%
Short Float3.77%EarningsJun 05/a
Analyst Recom1.85Target Price32.75
Avg Volume494.38K52W Range13.97 - 32.00
Couchbase, Inc. engages in the development of document database management solutions. It offers its Couchbase platform to developers to build enterprise web, mobile, and Internet of things applications that support massive data volumes in real time. The company was founded by Phillips James, Dustin Sallings, Damien Katz, Jan Lehnardt, Phillips James, and J. Chris Anderson in 2008, and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chow MargaretSVP & Chief Legal OfficerMay 20 '24Option Exercise7.751,0668,262211,495May 21 05:45 PM
Chow MargaretSVP & Chief Legal OfficerMay 20 '24Sale27.501,06629,315210,429May 21 05:45 PM
Chow MargaretSVP & Chief Legal OfficerMay 17 '24Option Exercise7.753,93430,488214,363May 21 05:45 PM
Chow MargaretSVP & Chief Legal OfficerMay 17 '24Sale27.533,934108,307210,429May 21 05:45 PM
Cain Matthew MChair, President, and CEOMay 15 '24Sale26.5810,053267,174873,405May 17 06:55 PM
CYTO - Altamira Therapeutics Ltd - Stock Price Chart
TickerCYTO [NASD]
CompanyAltamira Therapeutics Ltd
CountryBermuda
IndustryBiotechnology
Market Cap3.40MEPS (ttm)-
P/E-EPS this Y73.68%
Forward P/E-EPS next Y25.88%
PEG-EPS past 5Y50.52%
P/S-EPS next 5Y-
P/B-EPS Q/Q87.98%
Dividend-Sales Q/Q-
Insider Own0.89%Inst Own0.07%
Insider Trans0.00%Inst Trans19.68%
Short Float4.56%EarningsApr 10/b
Analyst Recom1.00Target Price287.34
Avg Volume2.05M52W Range1.35 - 17.60
May-28-24 10:31AM Altamira Therapeutics Provides Business Update (GlobeNewswire) -9.55%
May-24-24 08:45AM Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 (GlobeNewswire)
May-23-24 08:47AM Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal (GlobeNewswire) +19.58%
May-01-24 08:47AM Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation (GlobeNewswire)
Apr-24-24 08:47AM Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal (GlobeNewswire) -8.86%
Apr-17-24 08:00AM Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on April 18, 2024 (GlobeNewswire) -9.20%
Apr-15-24 08:00AM Diamond Equity Research Initiates Coverage on Altamira Therapeutics Ltd. (NASDAQ: CYTO) (GlobeNewswire) -9.29%
Apr-12-24 08:20AM Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Apr-10-24 08:00AM Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results (GlobeNewswire) +7.53%
Apr-04-24 08:45AM Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024 (GlobeNewswire) +7.73%
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
12345678910